loader
Please Wait
Applying Filters...

Looking for Octocrylene (USP)? Find Granulation used in Octocrylene (USP) to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 14Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3SPI Pharma

02 44BASF

03 12Corel Pharma Chem

04 1Gangwal Chemicals

05 2Hayashibara

06 1Ingredion Pharma Solutions

07 1Kima Chemical

08 4Lubrizol Life Science Health

09 3Microlex e.U

10 4Pharmatrans-Sanaq

11 1Pluviaendo

12 10Roquette

13 3Sigachi Industries

14 5The Dow Chemical Company

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

Grade : Oral

Brand Name : Aluminum Hydroxide 0200

Excipient Details : Aluminum hydroxide dried gel product (powder) 0200 is typically used in wet granulation processes to manufacture antacid tablets.

Pharmacopoeia Ref : USP, EP

Technical Specs : Tapped Density: 0.16-0.25; PSD D50: 12 µm

Grade : Oral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet

Category : Granulation

Brand : ALUMINUM HYDROXIDE 0200

Applications : Aluminum hydroxide dried gel product (powder) 0200 is typically used in wet granulation processes to manufacture antacid tablets.

Pharmacopoeia Ref : USP, EP

Technical Specs : Tapped Density: 0.16-0.25; PSD D50: 12 µm

Grade : Oral

arrow

04

arrow
OTS 2025
Not Confirmed

05

arrow
OTS 2025
Not Confirmed
arrow
OTS 2025
Not Confirmed

Brand : KOLLIDON SR

Applications : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specs : Not Available

Grade : Not Available

arrow
blank

08

arrow
OTS 2025
Not Confirmed
arrow
OTS 2025
Not Confirmed
blank

10

arrow
OTS 2025
Not Confirmed
arrow
OTS 2025
Not Confirmed
blank